ClinConnect ClinConnect Logo
Search / Trial NCT07040735

Low-Flow Anesthesia and Open-Heart Surgery

Launched by ÇAĞRI ÖZDEMIR · Jun 18, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Low Flow Anesthesia Hemodynamics Open Heart Surgery

ClinConnect Summary

This clinical trial is studying a special way of giving anesthesia called low-flow anesthesia (LFA) during open-heart surgery. LFA involves recycling some of the air a patient breathes out, mixing it with fresh gas, and sending it back to the lungs, which may help manage how the heart and blood flow react during surgery. The study aims to find out if different amounts of fresh gas used with LFA affect heart function during these operations.

Adults aged 18 and older who are scheduled for open-heart surgery and are in generally stable health groups (called ASA I-IV) may be eligible to join. However, emergency cases, people under 18, those who have had open-heart surgery before, or those who cannot have inhaled anesthesia won’t be able to participate. If you join, you will receive low-flow anesthesia during your surgery, and the medical team will carefully monitor your heart and blood flow to see how different gas flow rates affect you. Participation is voluntary, and you will be asked to sign a consent form before joining. This study is not yet recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • -≥18 years and scheduled for open-heart surgery patients
  • -ASA I-II-III-IV physical class
  • Exclusion Criteria:
  • Emergency cases
  • Patients under 18 years of age
  • Patients who have had open heart surgery before
  • Patients for whom the use of inhaled anesthetic agents is contraindicated
  • Patients who do not sign a voluntary consent form

About çağrı özdemir

Çağrı Özdemir is a clinical trial sponsor dedicated to advancing medical research through the support and management of innovative clinical studies. Committed to upholding the highest standards of scientific integrity and patient safety, Çağrı Özdemir plays a pivotal role in facilitating the development of new treatments and therapies aimed at improving health outcomes.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported